Literature DB >> 17420939

Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis.

Randall H Grose1, Fiona M Thompson, Alan G Baxter, Daniel G Pellicci, Adrian G Cummins.   

Abstract

The aim of this study was to investigate whether immunoregulatory invariant NK T cells are deficient in Crohn's disease or ulcerative colitis. Blood was collected for flow cytometry from 106 Crohn's disease, 91 ulcerative colitis, and 155 control subjects. Invariant NK T cells were assessed by Valpha24 and (alpha-galactosylceramide/CD1d tetramer markers. Intracellular cytokine was measured after in vitro anti-CD3 antibody stimulation. Valpha24+ T cells were quantified in ileocolonic biopsies as mRNA by real-time PCR and by immunofluorescence. Circulating invariant NK T cells were 5.3% of the control levels in Crohn's (P < 0.001) and 7.9% of the control levels in ulcerative colitis (P < 0.001). Interleukin-4 production was impaired in Crohn's disease and ulcerative colitis. Intestinal Valpha24 mRNA expression was 7% in Crohn's disease (P < 0.05) and 9% in ulcerative colitis (P < 0.05). Intestinal Valpha24+ T cells were 23% in Crohn's disease but not reduced in ulcerative colitis. We conclude that invariant NK T cells are deficient in Crohn's disease and in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17420939     DOI: 10.1007/s10620-006-9261-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  32 in total

Review 1.  NKT cells: facts, functions and fallacies.

Authors:  D I Godfrey; K J Hammond; L D Poulton; M J Smyth; A G Baxter
Journal:  Immunol Today       Date:  2000-11

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

3.  Failure to induce oral tolerance in Crohn's and ulcerative colitis patients: possible genetic risk.

Authors:  Thomas A Kraus; Lisa Toy; Lisa Chan; Joseph Childs; Adam Cheifetz; Lloyd Mayer
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

4.  Peritz' F test: basic program of a robust multiple comparison test for statistical analysis of all differences among group means.

Authors:  J F Harper
Journal:  Comput Biol Med       Date:  1984       Impact factor: 4.589

5.  Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.

Authors:  L J Saubermann; P Beck; Y P De Jong; R S Pitman; M S Ryan; H S Kim; M Exley; S Snapper; S P Balk; S J Hagen; O Kanauchi; K Motoki; T Sakai; C Terhorst; Y Koezuka; D K Podolsky; R S Blumberg
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

6.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

Authors:  S B Wilson; S C Kent; K T Patton; T Orban; R A Jackson; M Exley; S Porcelli; D A Schatz; M A Atkinson; S P Balk; J L Strominger; D A Hafler
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

7.  Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner.

Authors:  M Nieda; A Nicol; Y Koezuka; A Kikuchi; T Takahashi; H Nakamura; H Furukawa; T Yabe; Y Ishikawa; K Tadokoro; T Juji
Journal:  Hum Immunol       Date:  1999-01       Impact factor: 2.850

8.  Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.

Authors:  R Karttunnen; E J Breese; J A Walker-Smith; T T MacDonald
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

9.  Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

Authors:  J L Matsuda; O V Naidenko; L Gapin; T Nakayama; M Taniguchi; C R Wang; Y Koezuka; M Kronenberg
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307

10.  Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis.

Authors:  T Sumida; A Sakamoto; H Murata; Y Makino; H Takahashi; S Yoshida; K Nishioka; I Iwamoto; M Taniguchi
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  19 in total

1.  Deficiency of 6B11+ invariant NK T-cells in celiac disease.

Authors:  Randall H Grose; Fiona M Thompson; Adrian G Cummins
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

Review 2.  Old and New Lymphocyte Players in Inflammatory Bowel Disease.

Authors:  Paolo Giuffrida; Gino Roberto Corazza; Antonio Di Sabatino
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

Review 3.  Interleukin 23 in Crohn's disease.

Authors:  Ahmet Eken; Akhilesh K Singh; Mohamed Oukka
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

4.  Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease.

Authors:  Aron Cseh; Barna Vasarhelyi; Kriszta Molnar; Balazs Szalay; Peter Svec; Andras Treszl; Antal Dezsofi; Peter-Laszlo Lakatos; Andras Arato; Tivadar Tulassay; Gabor Veres
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

5.  Control of Tissue-Resident Invariant NKT Cells by Vitamin A Metabolites and P2X7-Mediated Cell Death.

Authors:  Qingyang Liu; Chang H Kim
Journal:  J Immunol       Date:  2019-07-15       Impact factor: 5.422

6.  Dietary and Microbial Oxazoles Induce Intestinal Inflammation by Modulating Aryl Hydrocarbon Receptor Responses.

Authors:  Shankar S Iyer; Thomas Gensollen; Amit Gandhi; Sungwhan F Oh; Joana F Neves; Frederic Collin; Richard Lavin; Carme Serra; Jonathan Glickman; Punyanganie S A de Silva; R Balfour Sartor; Gurdyal Besra; Russell Hauser; Anthony Maxwell; Amadeu Llebaria; Richard S Blumberg
Journal:  Cell       Date:  2018-05-17       Impact factor: 41.582

Review 7.  The functions of type I and type II natural killer T cells in inflammatory bowel diseases.

Authors:  Chia-Min Liao; Michael I Zimmer; Chyung-Ru Wang
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

8.  The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.

Authors:  F Meylan; Y-J Song; I Fuss; S Villarreal; E Kahle; I-J Malm; K Acharya; H L Ramos; L Lo; M M Mentink-Kane; T A Wynn; T-S Migone; W Strober; R M Siegel
Journal:  Mucosal Immunol       Date:  2010-10-27       Impact factor: 7.313

9.  Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.

Authors:  Kenneth Andrew Ross
Journal:  BMC Med       Date:  2011-02-03       Impact factor: 8.775

10.  Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections.

Authors:  Jin S Im; Tae-Jin Kang; Seong-Beom Lee; Chi-Hong Kim; Sang-Haak Lee; Manjunatha M Venkataswamy; Evan R Serfass; Bing Chen; Petr A Illarionov; Gurdyal S Besra; William R Jacobs; Gue-Tae Chae; Steven A Porcelli
Journal:  Clin Immunol       Date:  2008-03-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.